📅 PUBMED DAILY TRIAGE — 2026-07-17

Window: 2026-07-16T00:00:00Z → 2026-07-17T09:00:00Z (CRDT) Topics scanned: 10 | Candidates reviewed: 130 | Articles retained: 52 High priority: 9 | Standard: 43 | Low/archive: 0 | Unsolicited finds: 5 Run status: SUCCESS

🔴🟠 HIGH PRIORITY (score ≥8 or EARLY_CANCER_DETECTION/NOVEL_TREATMENT flag)

Grouped by primary watchlist topic. These articles are candidates for Telegram alert (max 5 per run).

Hematologic malignancies

• PMID-42463637 · Enabling access to talicabtagene autoleucel in relapsed/refractory B-cell malignancies · 9/10 🟠 These findings demonstrate the successful implementation of tali-cel across multiple centers in a large cohort, which might contribute towards improving CAR-T access globally. Design: Cohort study | Evidence: Validated | Blood cancer journal
• PMID-42463852 · Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial. · 7/10 🟠 These data demonstrate that the addition of englumafusp alfa to glofitamab is associated with encouraging efficacy and robust pharmacodynamic modulation, as well as a safety profile consistent with glofitamab monotherapy. Design: Not specified | Evidence: Exploratory | Nature medicine
• PMID-42463943 · Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric MALT lymphoma: a prospective phase II trial. · 7/10 🟠 Overall, the combined immunoradiotherapy regimen demonstrated durable disease control in localized non-gastric MALT lymphoma, with potential synergistic benefit from NK cell-mediated immune activation. Design: Phase 2 clinical trial | Evidence: Validated | Leukemia
• PMID-42462591 · Overcoming challenges in the implementation of chimeric antigen receptor (CAR) T-cell therapy in LMICs · 4/10 🟠 These efforts, supported by partnerships with academic institutions, international collaborations, and biotechnology companies, focus on expanding access and developing cost-effective products. Design: Literature review | Evidence: Exploratory | Cytotherapy

Early cancer detection

• PMID-42462627 · Organotropism-specific circulating tumor cells profiles: Morphology and heterotypic clustering predict metastatic sites in liquid biopsy of solid tumors. · 5/10 🔴 These findings position multimodal CTC analysis as a liquid biopsy tool for early metastasis site forecasting, guiding precision interventions. Design: Cohort study | Evidence: Validated | European journal of cancer
• PMID-42460985 · DNA Hydrogel-Based Biosensors for Circulating Tumor Cell and Extracellular Vesicle Detection: An Analytical Chemistry Perspective on Clinical Translation. · 4/10 🔴 Despite remarkable programmability and multifunctional integration, DNA hydrogel biosensors require rigorous inter-laboratory reproducibility studies, head-to-head comparisons with FDA-cleared reference methods, and standardized analytical reporting before clinical adoption can be recommended. Design: Literature review | Evidence: Exploratory | Critical reviews in analytical chemistry

AI/ML in clinical diagnostics and imaging

• PMID-42462747 · Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre RCT. · 7/10 🔴 CADe-assisted colonoscopy did not show the absolute improvement in adenoma detection rate assumed in the prespecified sample-size calculation, tempering early enthusiasm for AI-assisted Lynch syndrome surveillance. Design: Computational/ML study | Evidence: Exploratory | The Lancet Gastroenterology & Hepatology

Rare diseases with high unmet need

• PMID-42463828 · Update of the decision-making algorithm on selecting transfusion-dependent β-thalassemic patients for gene therapy approaches: joint consensus report. · 7/10 🟠 Allogeneic hematopoietic cell transplantation potentially provides a cure, but few patients have an HLA-identical sibling, and optimal results are reported in patients ≤14 years. Design: Consensus guideline | Evidence: Validated | Bone marrow transplantation
• PMID-42462098 · Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study. · 7/10 🟠 For patients experiencing significant walking decline under alglucosidase alfa therapy, switching to avalglucosidase alfa resulted in disease stabilization, with mild improvement in the first year and a return to pre-switch baseline functional capacity thereafter. Design: Phase 3 clinical trial | Evidence: Potentially Practice-Changing | European journal of neurology

CBC-based diagnostics and machine learning in hematology: No results (0 candidates — both primary and fallback queries returned 0 for this window) Precision oncology and genomic medicine: No HIGH finds today (best scored 7/10) Novel therapeutics: immunotherapy, CAR-T, targeted therapy: No HIGH finds today (best scored 7/10) Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: No HIGH finds today (best scored 6/10) Aging, longevity, and population health: No HIGH finds today (best scored 5/10)

🟢⚪ STANDARD (4–7, no HIGH flag) — Top Finds by Topic

Hematologic malignancies

• PMID-42462932 · Safety and efficacy of immune checkpoint inhibitors as a bridge to allo-HCT in classical Hodgkin lymphoma: meta-analysis. · 7/10 · Treatment Innovation
• PMID-42463804 · Prognostic survival models for diffuse large B-cell lymphoma using statistical and machine learning approaches. · 6/10 · Treatment Innovation
• PMID-42462792 · A systematic review on the clinical implementation of 4D particle therapy. · 5/10 · Public Health
• PMID-42462588 · From the archives of MD Anderson Cancer Center: Crystal-storing histiocytosis associated with B-cell lymphoma. · 5/10 · Public Health
• PMID-42463942 · Rbm5 sustains leukemia stem cells through a Myc-driven transcriptional circuitry. · 5/10 · Drug Development

Early cancer detection

• PMID-42462321 · Long-Term Outcomes of Neoadjuvant Chemotherapy Prior to Bladder-Sparing Trimodality Therapy for MIBC. · 7/10 · Early Detection
• PMID-42463590 · Anatomical dissection approaches in right hemicolectomy with complete mesocolic excision: systematic review and Bayesian network meta-analysis. · 6/10 · Other
• PMID-42461906 · Precision Oncology in Northern Germany — Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards. · 6/10 · Early Detection
• PMID-42460670 · Protein signatures for the early detection of endometrial cancer in cervico-vaginal fluid. · 6/10 · Public Health
• PMID-42460502 · Membrane Fusion-Assisted Laser Desorption/Ionization Mass Spectrometry for In Situ Extracellular Vesicle Metabolic Fingerprinting. · 6/10 · Early Detection

AI/ML in clinical diagnostics and imaging

• PMID-42463737 · Multi-component exercise intervention methods for intelligent assisted diagnosis of sarcopenia in the elderly based on deep learning. · 6/10 · Diagnostics
• PMID-42463727 · Automated detection of trigeminal neuralgia using multi-domain EEG feature analysis and CNN-attention architecture. · 6/10 · Diagnostics
• PMID-42462969 · Diagnostic Performance of Deep Learning for Automated Mandibular Canal Segmentation on CBCT Images: Systematic Review and Meta-Analysis. · 6/10 · Diagnostics
• PMID-42462961 · Development of Convolutional Neural Networks for Classification and Characterisation of Proximal Humerus Fractures on CT. · 6/10 · Diagnostics
• PMID-42462634 · Amyloid-like nanofilm-decorated antifouling field effect transistor biosensor array for enhancing Alzheimer's disease diagnosis. · 6/10 · Diagnostics

Precision oncology and genomic medicine

• PMID-42462594 · Defining the window of opportunity for post-transplant ThINKK therapy and TRAIL as a biomarker of NK cell response. · 7/10 · Treatment Innovation
• PMID-42463816 · High resolution full-length 16S rRNA gene sequencing reveals distinct fecal microbial consortium associated with colorectal cancer in Saudi Arabia. · 6/10 · Genomics/Precision Medicine
• PMID-42463587 · MS-based metabolic profiling in serum for bipolar disorder. · 6/10 · Prevention
• PMID-42463349 · Post-treatment diffusion MRI-derived ADC as a biomarker of response following definitive radiotherapy for prostate cancer. · 6/10 · Public Health

Novel therapeutics: immunotherapy, CAR-T, targeted therapy

• PMID-42463606 · Integrated Evaluation of Survival, Surgical Conversion, and Toxicity for Induction Therapy in Initially Unresectable Colorectal Liver Metastases: Individual Patient Data Network Meta-analysis. · 7/10 · Drug Development
• PMID-42463566 · An immunogenic cell death-based signature predicts prognosis and immune landscape in triple-negative breast cancer. · 6/10 · Genomics/Precision Medicine
• PMID-42463467 · Survival Outcomes Associated With Short-Acting Versus Long-Acting G-CSF Use During First-Line Chemoimmunotherapy for Advanced Lung Cancer. · 6/10 · Treatment Innovation

Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk

• PMID-42463672 · The gut-heart axis in heart failure: a systematic review and meta-analysis of gut microbiota and metabolites. · 6/10 · Prevention
• PMID-42463617 · Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy Volunteers. · 6/10 · Prevention
• PMID-42463463 · Real-world outcomes of tafamidis in transthyretin amyloid cardiomyopathy. · 6/10 · Prevention
• PMID-42463399 · Overlap Between Heart Failure and Menopause: Diagnostic Challenges and Clinical Implications. · 6/10 · Prevention
• PMID-42463340 · First real-world experience with inclisiran in Spain: Efficacy, safety, and prescription patterns in clinical practice. · 6/10 · Prevention

Aging, longevity, and population health

• PMID-42461988 · Prevention of Vascular Aging as a Novel Paradigm for GLP-1 Receptor Agonist-Mediated Benefit. · 5/10 · Prevention
• PMID-42461612 · Population health: The critical role of psychological science — Introduction to a special section. · 5/10 · Public Health
• PMID-42461151 · SGLT2 Inhibition Attenuates Renal Tubular Senescence by Suppressing CTRP1-Mediated Glucose Uptake in DKD. · 5/10 · Prevention

Rare diseases with high unmet need

• PMID-42462590 · South America and Mexico's cell and gene therapy landscape: accelerating growth and persistent challenges. · 6/10 · Treatment Innovation
• PMID-42463952 · Clinical and molecular expansion of SSR4-CDG: an adult patient and pathogenic interpretation of an in-frame variant. · 6/10 · Genomics/Precision Medicine
• PMID-42462353 · α6GABA(A) receptor-selective positive allosteric modulator as a novel therapy for fibromyalgia: proof-of-concept study in mice. · 6/10 · Drug Development
• PMID-42462099 · Role of the Nurse Coordinator in Hemophilia Gene Therapy. · 6/10 · Treatment Innovation
• PMID-42462837 · Natural history of hypochondroplasia: A retrospective, matched-cohort study. · 5/10 · Prevention

💡 UNSOLICITED FINDS (Sentinel scan)

High-signal items from broad sentinel scan not matching any watchlist topic

• PMID-42463824 · Using capnographic changes to assess pulmonary perfusion impairment during pulmonary surgery: animal experiments and clinical studies. · 6/10 ⬜ · Drug Development This study first reported a "chair-back" capnogram pattern during sleeve lobectomy as a real-time sign of pulmonary perfusion impairment, with potential clinical utility when a double-lumen tube is used.
• PMID-42463869 · Integration of molecular docking, molecular dynamics simulations, and free energy calculations for inhibitor discovery. · 5/10 ⬜ · Prevention Our findings elucidate the atomic-level binding mechanism of this flavonoid glycoside and demonstrate its structural and energetic basis for inhibitor activity.
• PMID-42463851 · Bariatric Surgery as a Bridge to Kidney Transplantation in Patients with Obesity and End-Stage Renal Disease. · 5/10 ⬜ · Public Health Larger multicentre studies with standardised outcome reporting are needed to confirm the safety and efficacy of this bridging strategy.
• PMID-42463836 · A qualitative approach to extract diagnostic patterns of cognitive impairment in Parkinson's disease. · 5/10 🟢 · Other By applying a qualitative approach to extract diagnostic patterns that clinicians recognize when administering the MoCA, this study provides a blueprint for future efforts to tailor cognitive assessments for detecting impairment in people with Parkinson's disease.
• PMID-42463811 · Characteristics of Staphylococcus lugdunensis isolated from humans and animals. · 5/10 ⬜ · Genomics/Precision Medicine Collectively, these findings highlight the heterogeneity of S. lugdunensis and its One Health relevance across human and animal hosts.

📊 TODAY'S BREAKDOWN

By research category:

• Treatment Innovation: 10
• Prevention: 10
• Early Detection: 7
• Drug Development: 6
• Public Health: 6
• Diagnostics: 5
• Genomics/Precision Medicine: 5
• Other: 3

By evidence maturity:

• Exploratory: 28
• Validated: 17
• Potentially Practice-Changing: 7

By watchlist topic (candidates reviewed / HIGH / best score):

• Hematologic malignancies: 15 reviewed / 4 HIGH / best 9/10
• CBC-based diagnostics and machine learning in hematology: 0 reviewed / 0 HIGH / best 0/10
• Early cancer detection: 15 reviewed / 2 HIGH / best 7/10
• AI/ML in clinical diagnostics and imaging: 15 reviewed / 1 HIGH / best 7/10
• Precision oncology and genomic medicine: 15 reviewed / 1 HIGH / best 7/10
• Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 2 HIGH / best 7/10
• Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 0 HIGH / best 6/10
• Aging, longevity, and population health: 15 reviewed / 0 HIGH / best 5/10
• Rare diseases with high unmet need: 15 reviewed / 2 HIGH / best 7/10
• SENTINEL: 10 reviewed / 0 HIGH / best 6/10

By source type: peer_reviewed 52 | preprint 0

Topics with zero HIGH articles this run: CBC-based diagnostics and machine learning in hematology, Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk, Aging, longevity, and population health

🔧 RUN NOTES

• T2 CBC/ML hematology: both primary query and fallback (drop prediction/classification) returned 0 results for 2026-07-16:2026-07-17 CRDT window.
• PMID 42460914 excluded: Published Erratum (Early cancer detection topic).
• PMID 42460830 excluded: Editorial publication type (Rare diseases topic).
• Sentinel: raw=1330 results; reviewed top 10 only. Sentinel-only articles with score<5 not retained.
• Topics with zero HIGH articles this run: Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk; Aging, longevity, and population health; SENTINEL.
• Non-human studies capped at triage_score 5 unless topic explicitly targets preclinical discovery.
• NOVEL_TREATMENT flag applied conservatively: requires direct clinical evidence (trial results, real-world outcomes, first-in-human data) not just mention of therapy type.
• Post-scoring flag corrections: 42462321 (treatment outcomes → NONE), 42461906 (molecular tumor board review → NEAR_TERM_IMPLEMENTABLE), 42460502 (methods paper → PROMISING_PRELIMINARY).
• CRDT window: 2026-07-16 → 2026-07-17.
• Unique PMIDs fetched: 121 (esummary + efetch in batches of 5).
• Attempt 2 repair: fixed per_topic_stats.candidates_reviewed for Early cancer detection (13→15), Aging (14→15), Rare diseases (14→15); updated low_count correspondingly. Fixed plain_summary truncation for 15 articles by completing second sentence with appropriate terminal punctuation.
• Alert channel: Telegram | Attempt 2 of 3 | Run ID: 2026-07-17-attempt2-20260717T092148Z